217 related articles for article (PubMed ID: 37312443)
1. Recent Insights into Nanoparticulate Carrier Systems of Curcumin and its Clinical Perspective in the Management of Various Health Issues.
Harwansh RK; Yadav M; Deshmukh R; Rahman A
Curr Pharm Des; 2023 Jun; ():. PubMed ID: 37312443
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
Ma Z; Wang N; He H; Tang X
J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
[TBL] [Abstract][Full Text] [Related]
3. Properties, Extraction Methods, and Delivery Systems for Curcumin as a Natural Source of Beneficial Health Effects.
Zielińska A; Alves H; Marques V; Durazzo A; Lucarini M; Alves TF; Morsink M; Willemen N; Eder P; Chaud MV; Severino P; Santini A; Souto EB
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32635279
[TBL] [Abstract][Full Text] [Related]
4. Design and in vitro evaluation of a new nano-microparticulate system for enhanced aqueous-phase solubility of curcumin.
Guzman-Villanueva D; El-Sherbiny IM; Herrera-Ruiz D; Smyth HD
Biomed Res Int; 2013; 2013():724763. PubMed ID: 23984402
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
Mohanty C; Das M; Sahoo SK
Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
[TBL] [Abstract][Full Text] [Related]
6. pH - Responsive colloidal carriers assembled from β-lactoglobulin and Epsilon poly-L-lysine for oral drug delivery.
Pujara N; Giri R; Wong KY; Qu Z; Rewatkar P; Moniruzzaman M; Begun J; Ross BP; McGuckin M; Popat A
J Colloid Interface Sci; 2021 May; 589():45-55. PubMed ID: 33450459
[TBL] [Abstract][Full Text] [Related]
7. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
Kharat M; McClements DJ
J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
[TBL] [Abstract][Full Text] [Related]
9. Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights.
Jacob S; Kather FS; Morsy MA; Boddu SHS; Attimarad M; Shah J; Shinu P; Nair AB
Nanomaterials (Basel); 2024 Apr; 14(8):. PubMed ID: 38668166
[TBL] [Abstract][Full Text] [Related]
10. Oral bioavailability of curcumin: problems and advancements.
Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
[TBL] [Abstract][Full Text] [Related]
11. Application of different nanocarriers for encapsulation of curcumin.
Rafiee Z; Nejatian M; Daeihamed M; Jafari SM
Crit Rev Food Sci Nutr; 2019; 59(21):3468-3497. PubMed ID: 30001150
[TBL] [Abstract][Full Text] [Related]
12. Biomedical Applications and Bioavailability of Curcumin-An Updated Overview.
Sohn SI; Priya A; Balasubramaniam B; Muthuramalingam P; Sivasankar C; Selvaraj A; Valliammai A; Jothi R; Pandian S
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959384
[TBL] [Abstract][Full Text] [Related]
13. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
[TBL] [Abstract][Full Text] [Related]
14. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
15. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.
Anand P; Nair HB; Sung B; Kunnumakkara AB; Yadav VR; Tekmal RR; Aggarwal BB
Biochem Pharmacol; 2010 Feb; 79(3):330-8. PubMed ID: 19735646
[TBL] [Abstract][Full Text] [Related]
16. Recent updates in curcumin delivery.
Obeid MA; Alsaadi M; Aljabali AA
J Liposome Res; 2023 Mar; 33(1):53-64. PubMed ID: 35699160
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and curcumin-loaded nanoparticles: antipathogenic and antiparasitic activities.
Rai M; Ingle AP; Pandit R; Paralikar P; Anasane N; Santos CAD
Expert Rev Anti Infect Ther; 2020 Apr; 18(4):367-379. PubMed ID: 32067524
[No Abstract] [Full Text] [Related]
18. Advances in nanotechnology-based delivery systems for curcumin.
Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
[TBL] [Abstract][Full Text] [Related]
19. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery.
Rapalli VK; Kaul V; Gorantla S; Waghule T; Dubey SK; Pandey MM; Singhvi G
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jan; 224():117392. PubMed ID: 31330421
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Loaded and Co-loaded Nanosystems: A Review from a Biological Activity Enhancement Perspective.
Araya-Sibaja AM; Wilhelm K; González-Aguilar GA; Vega-Baudrit JR; Salazar-López NJ; Domínguez-Avila JA; Navarro-Hoyos M
Pharm Nanotechnol; 2021; 9(2):85-100. PubMed ID: 33371864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
